Celanese Corporation (CE) Financial Statements
Celanese Corporation (CE) reported trailing twelve-month revenue of $9.7B (down 2.2% year on year) and net income of -$1.2B as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $708.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CECelanese CorporationFollow CE — free
—
Price chart with a free account
- Market cap
- 5.2B
- P/E TTM
- —
- Dividend yield
- 0.2%
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.08 | 5.92 | 6.76 | 6.42 | 6.51 | 6.80 | 5.67 | 5.39 | 6.14 | 7.16 | 6.30 | 5.66 | 8.54 | 9.67 | 10.93 | 10.27 | 9.54 | 9.71 | |
| Gross profit | 1.00 | 1.18 | 1.42 | 1.18 | 1.37 | 1.62 | 1.32 | 1.41 | 1.51 | 1.97 | 1.61 | 1.29 | 2.68 | 2.38 | 2.58 | 2.34 | 1.95 | 2.03 | |
| Research & development | 0.07 | 0.07 | 0.10 | 0.10 | 0.09 | 0.09 | 0.12 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.09 | 0.11 | 0.15 | 0.13 | 0.13 | 0.12 | |
| Operating income | 0.29 | 0.50 | 0.40 | 0.18 | 1.51 | 0.76 | 0.33 | 0.93 | 0.86 | 1.33 | 0.83 | 0.66 | 1.95 | 1.38 | 1.67 | -0.72 | -0.79 | -0.69 | |
| Pre-tax income | 0.25 | 0.54 | 0.47 | 0.32 | 1.61 | 0.94 | 0.49 | 1.03 | 1.08 | 1.51 | 0.99 | 2.25 | 2.25 | 1.42 | 1.16 | -1.02 | -1.22 | -1.12 | |
| Income tax | -0.24 | 0.11 | 0.04 | -0.06 | 0.51 | 0.31 | 0.20 | 0.12 | 0.21 | 0.29 | 0.12 | 0.25 | 0.33 | -0.49 | -0.80 | 0.51 | -0.09 | 0.02 | |
| Net income | 0.50 | 0.38 | 0.43 | 0.37 | 1.10 | 0.62 | 0.30 | 0.90 | 0.84 | 1.21 | 0.85 | 1.99 | 1.89 | 1.89 | 1.94 | -1.54 | -1.17 | -1.17 | |
| Diluted EPS ($) | 3.17 | 2.38 | 2.69 | 2.33 | 6.91 | 4.00 | 2.00 | 6.18 | 6.09 | 8.91 | 6.84 | 16.75 | 16.86 | 17.34 | 17.76 | -14.11 | -10.64 | -10.69 | |
| Diluted shares (bn) | 0.157 | 0.158 | 0.159 | 0.160 | 0.159 | 0.156 | 0.152 | 0.146 | 0.138 | 0.135 | 0.125 | 0.118 | 0.112 | 0.109 | 0.109 | 0.109 | 0.110 | — |
USD billions · SEC XBRL
Celanese Corporation — questions
- What is Celanese Corporation's revenue?
- $9.7B over the twelve months to 2026-06-30, down 2.2% year on year, from its 10-Q and 10-K filings.
- What is Celanese Corporation's net income?
- -$1.2B over the twelve months to 2026-06-30.
- What is Celanese Corporation's free cash flow?
- $708.0M over the twelve months to 2026-06-30.
- What are Celanese Corporation's diluted earnings per share?
- $-10.69 over the twelve months to 2026-06-30.
Every figure on this page comes from Celanese Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.